BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6324812)

  • 1. Inhibition by suloctidil of [3H] nitrendipine binding to cerebral cortex membranes.
    Chatelain P; Demol D; Roba J
    Biochem Pharmacol; 1984 Apr; 33(7):1099-103. PubMed ID: 6324812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]nitrendipine binding in the guinea pig left ventricle: effects of calcium and lanthanum.
    Fawzi AB; McNeill JH
    Eur J Pharmacol; 1984 Sep; 104(3-4):357-62. PubMed ID: 6437849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference of sodium with [3H]-nitrendipine binding to cardiac membranes.
    Schwartz J; Velly J
    Br J Pharmacol; 1985 Feb; 84(2):511-5. PubMed ID: 3156649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca2+ channel antagonist actions in bladder smooth muscle: comparative pharmacologic and [3H]nitrendipine binding studies.
    Yousif FB; Bolger GT; Ruzycky A; Triggle DJ
    Can J Physiol Pharmacol; 1985 May; 63(5):453-62. PubMed ID: 2994869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of temperature and allosteric modulators on [3H] nitrendipine binding: methods for detecting potential Ca2+ channel blockers.
    Holck M; Fischli W; Hengartner U
    J Recept Res; 1984; 4(1-6):557-69. PubMed ID: 6084712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
    Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
    J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]diltiazem binding to calcium channel antagonists recognition sites in rat cerebral cortex.
    Schoemaker H; Langer SZ
    Eur J Pharmacol; 1985 May; 111(2):273-7. PubMed ID: 2410283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
    Ferry DR; Goll A; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-affinity antibodies to the 1,4-dihydropyridine Ca2+-channel blockers.
    Campbell KP; Sharp A; Strom M; Kahl SD
    Proc Natl Acad Sci U S A; 1986 May; 83(9):2792-6. PubMed ID: 3010317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of [3H]nitrendipine binding to heart membranes of normotensive and spontaneously hypertensive rats.
    Chatelain P; Demol D; Roba J
    J Cardiovasc Pharmacol; 1984; 6(2):220-3. PubMed ID: 6200707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine.
    Gould RJ; Murphy KM; Snyder SH
    Mol Pharmacol; 1984 Mar; 25(2):235-41. PubMed ID: 6422256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent enhancement of [3H]nitrendipine binding in rat cerebral cortical and cardiac homogenates: a putative mechanism for the action of MDL 12,330A.
    Lee HR; Jaros JA; Roeske WR; Wiech NL; Ursillo R; Yamamura HI
    J Pharmacol Exp Ther; 1985 Jun; 233(3):611-6. PubMed ID: 3159884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric modulation of [3H]nitrendipine binding to cardiac and cerebral cortex membranes by amiodarone.
    Nokin P; Clinet M; Swillens S; Delisée C; Meysmans L; Chatelain P
    J Cardiovasc Pharmacol; 1986; 8(5):1051-7. PubMed ID: 2429079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel calcium antagonist binding site in rat brain by SR 33557.
    Kenny BA; Fraser S; Spedding M
    Br J Pharmacol; 1993 Jan; 108(1):93-9. PubMed ID: 7679034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes.
    Bellemann P; Ferry D; Lübbecke F; Glossman H
    Arzneimittelforschung; 1981; 31(12):2064-7. PubMed ID: 7199299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of phenoxybenzamine with muscarinic receptors and calcium channels.
    Gengo PJ; Yousif F; Janis RA; Triggle DJ
    Biochem Pharmacol; 1984 Nov; 33(21):3445-9. PubMed ID: 6093812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific high affinity binding of the calcium channel antagonist, [3H]nitrendipine, to rat liver microsomes.
    Gopalakrishnan V; Triggle CR
    Can J Physiol Pharmacol; 1984 Sep; 62(9):1249-52. PubMed ID: 6498637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro vasorelaxing activity of suloctidil.
    Calderon P; van Dorsser W; Geöcze von Szendroi K; De Mey JG; Roba J
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):101-13. PubMed ID: 3030204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
    Boles RG; Yamamura HI; Schoemaker H; Roeske WR
    J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative potencies of calcium channel antagonists and antischizophrenic drugs on central and peripheral calcium channel binding sites.
    Quirion R; Lafaille F; Nair NP
    J Pharm Pharmacol; 1985 Jun; 37(6):437-40. PubMed ID: 2410588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.